Zurich Cantonal Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,311
Closed -$103K 2637
2016
Q4
$103K Hold
8,311
﹤0.01% 1283
2016
Q3
$114K Buy
8,311
+4,015
+93% +$40.3K ﹤0.01% 1184
2016
Q2
$32K Hold
4,296
﹤0.01% 1771
2016
Q1
$27K Hold
4,296
﹤0.01% 1830
2015
Q4
$27K Buy
4,296
+2,338
+119% +$15.3K ﹤0.01% 1851
2015
Q3
$11K Buy
1,958
+1,143
+140% +$8.8K ﹤0.01% 1958
2015
Q2
$7K Hold
815
﹤0.01% 1699
2015
Q1
$7K Buy
+815
New +$6.03K ﹤0.01% 1674
2014
Q3
Sell
-300,000
Closed -$1.91M 1010
2014
Q2
$1.91M Buy
300,000
+100,000
+50% +$688K 0.06% 401
2014
Q1
$1.61M Hold
200,000
0.05% 406
2013
Q4
$1.36M Buy
200,000
+55,000
+38% +$297K 0.04% 408
2013
Q3
$2.67M Sell
145,000
-45,000
-24% -$874K 0.09% 238
2013
Q2
$3.32M Buy
+190,000
New +$3.37M 0.12% 178

Other funds holding ARIA

Zurich Cantonal Bank's ARIA Position: Q1 2017 in Review

Zurich Cantonal Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 8,311 shares — an estimated $103K sold.

Zurich Cantonal Bank first reported a position in ARIA in Q2 2013 and held it in 13 quarters. The position peaked at $3.32M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Zurich Cantonal Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Zurich Cantonal Bank sold 8,311 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $103K.
  • Zurich Cantonal Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 13 quarters.
  • Zurich Cantonal Bank's Ariad Pharmaceuticals Inc position peaked at $3.32M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Zurich Cantonal Bank's 13F filing for Q1 2017, filed 4 May 2017.